Marshall Wace’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,636
Closed -$485K 2505
2024
Q1
$485K Buy
+6,636
New +$485K ﹤0.01% 1695
2023
Q4
Sell
-6,333
Closed -$379K 2093
2023
Q3
$379K Buy
+6,333
New +$379K ﹤0.01% 1511
2023
Q2
Sell
-27,583
Closed -$2.03M 2272
2023
Q1
$2.03M Sell
27,583
-65,280
-70% -$4.8M ﹤0.01% 1160
2022
Q4
$6.2M Buy
92,863
+28,931
+45% +$1.93M 0.01% 917
2022
Q3
$3.43M Hold
63,932
0.01% 1342
2022
Q2
$3.56M Buy
+63,932
New +$3.56M 0.01% 1347
2021
Q4
Sell
-14,068
Closed -$1.22M 3398
2021
Q3
$1.22M Buy
+14,068
New +$1.22M 0.01% 1467
2021
Q1
Sell
-10,283
Closed -$638K 2343
2020
Q4
$638K Buy
+10,283
New +$638K ﹤0.01% 1247
2020
Q2
Sell
-8,140
Closed -$369K 1755
2020
Q1
$369K Buy
+8,140
New +$369K ﹤0.01% 1033
2019
Q3
Sell
-48,419
Closed -$3.45M 1759
2019
Q2
$3.45M Sell
48,419
-41,607
-46% -$2.96M 0.03% 586
2019
Q1
$7.06M Sell
90,026
-157,694
-64% -$12.4M 0.07% 352
2018
Q4
$21M Buy
247,720
+245,965
+14,015% +$20.8M 0.21% 107
2018
Q3
$301K Sell
1,755
-7,321
-81% -$1.26M ﹤0.01% 1009
2018
Q2
$1.17M Buy
+9,076
New +$1.17M 0.02% 489
2015
Q1
Sell
-152,490
Closed -$5.06M 874
2014
Q4
$5.06M Sell
152,490
-158,782
-51% -$5.27M 0.07% 310
2014
Q3
$9.13M Buy
311,272
+305,841
+5,631% +$8.97M 0.13% 195
2014
Q2
$211K Sell
5,431
-70,344
-93% -$2.73M ﹤0.01% 842
2014
Q1
$3.18M Buy
+75,775
New +$3.18M 0.06% 286